tradingkey.logo

DSS Inc

DSS
0.919USD
+0.037+4.20%
Close 02/06, 16:00ETQuotes delayed by 15 min
8.35MMarket Cap
LossP/E TTM

DSS Inc

0.919
+0.037+4.20%

More Details of DSS Inc Company

DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing.

DSS Inc Info

Ticker SymbolDSS
Company nameDSS Inc
IPO dateOct 27, 1993
CEOGrady (Jason)
Number of employees100
Security typeOrdinary Share
Fiscal year-endOct 27
Address275 Wiregrass Pkwy
CityWEST HENRIETTA
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code14586
Phone15852321500
Websitehttps://www.dssworld.com/
Ticker SymbolDSS
IPO dateOct 27, 1993
CEOGrady (Jason)

Company Executives of DSS Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Jason Grady
Mr. Jason Grady
Interim Chief Executive Officer
Interim Chief Executive Officer
125.00
--
Mr. Jose Escudero
Mr. Jose Escudero
Independent Director
Independent Director
51.00
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Wai Leung (William) Wu
Mr. Wai Leung (William) Wu
Lead Independent Director
Lead Independent Director
--
--
Mr. Tung Moe Chan
Mr. Tung Moe Chan
Director
Director
--
--
Mr. Todd D. Macko
Mr. Todd D. Macko
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Shui Yeung (Frankie) Wong, CPA
Mr. Shui Yeung (Frankie) Wong, CPA
Independent Director
Independent Director
--
--
Ms. Hiu Pan (Joanne) Wong
Ms. Hiu Pan (Joanne) Wong
Independent Director
Independent Director
--
--
Mr. Sheng Hon (Danny) Lim
Mr. Sheng Hon (Danny) Lim
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Jason Grady
Mr. Jason Grady
Interim Chief Executive Officer
Interim Chief Executive Officer
125.00
--
Mr. Jose Escudero
Mr. Jose Escudero
Independent Director
Independent Director
51.00
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Wai Leung (William) Wu
Mr. Wai Leung (William) Wu
Lead Independent Director
Lead Independent Director
--
--
Mr. Tung Moe Chan
Mr. Tung Moe Chan
Director
Director
--
--
Mr. Todd D. Macko
Mr. Todd D. Macko
Chief Financial Officer
Chief Financial Officer
--
--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2023Q1
FY2022
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Packaging Printing and Fabrication
484.10K
7.57%
Commercial and Security Printing
78.00K
1.22%
Real Property Rental Income
16.00K
0.25%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Packaging Printing and Fabrication
484.10K
7.57%
Commercial and Security Printing
78.00K
1.22%
Real Property Rental Income
16.00K
0.25%

Shareholding Stats

Updated: Sat, Jan 31
Updated: Sat, Jan 31
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Alset Ehome International Inc
36.04%
Chan (Heng Fai Ambrose)
20.31%
Global Biomedical Pte Ltd.
3.08%
The Vanguard Group, Inc.
0.64%
Renaissance Technologies LLC
0.31%
Other
39.63%
Shareholders
Shareholders
Proportion
Alset Ehome International Inc
36.04%
Chan (Heng Fai Ambrose)
20.31%
Global Biomedical Pte Ltd.
3.08%
The Vanguard Group, Inc.
0.64%
Renaissance Technologies LLC
0.31%
Other
39.63%
Shareholder Types
Shareholders
Proportion
Corporation
39.11%
Individual Investor
20.31%
Investment Advisor
0.85%
Hedge Fund
0.34%
Investment Advisor/Hedge Fund
0.23%
Research Firm
0.03%
Other
39.13%

Institutional Shareholding

Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
35
145.92K
2.15%
--
2025Q3
36
145.92K
2.15%
-17.92K
2025Q2
35
163.84K
2.17%
-884.00
2025Q1
35
164.73K
1.72%
+7.88K
2024Q4
38
121.90K
3.03%
-50.52K
2024Q3
42
172.42K
3.04%
-10.61K
2024Q2
46
183.03K
2.83%
+19.66K
2024Q1
49
163.37K
2.83%
-36.31K
2023Q4
48
186.92K
3.41%
+16.51K
2023Q3
52
170.94K
7.14%
-2.49K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Alset Ehome International Inc
3.65M
40.14%
-581.39K
-13.74%
Oct 06, 2025
Chan (Heng Fai Ambrose)
2.06M
22.62%
--
--
Oct 06, 2025
Global Biomedical Pte Ltd.
311.63K
3.43%
--
--
Oct 06, 2025
The Vanguard Group, Inc.
64.83K
0.71%
+43.10K
+198.36%
Sep 30, 2025
Renaissance Technologies LLC
31.45K
0.35%
+4.00K
+14.57%
Sep 30, 2025
Geode Capital Management, L.L.C.
22.84K
0.25%
+3.65K
+18.99%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
20.98K
0.23%
--
--
Sep 30, 2025
Citi Investment Research (US)
2.94K
0.03%
+2.94K
--
Sep 30, 2025
Tower Research Capital LLC
2.54K
0.03%
-1.89K
-42.63%
Sep 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
Date
Ex-dividend Date
Type
Ratio
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
KeyAI